Insilico Medicine Funding: $416M Raised, Series E (2025)
Insilico Medicine is based in Boston, Massachusetts. It has raised $416M in total funding. Latest round: Series E.
Insilico Medicine funding overview
Insilico Medicine is based in Boston, Massachusetts. Insilico Medicine has raised $416M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series E announced in June 2025. The round record for Insilico Medicine runs through 2025; nothing later has been disclosed. Investors on record include Warburg Pincus, Sequoia Capital, Orbimed, Mirae Asset Financial Group, Deep Knowledge Ventures, JHU A-Level Capital and 2 others. 8 distinct backers are named across the disclosed rounds.
Insilico Medicine at a glance
Total raised
$416M
Latest round
Series E
Latest round date
June 2025
Headquarters
Boston, Massachusetts
Notable investors
Warburg Pincus, Sequoia Capital, Orbimed, Mirae Asset Financial Group, Deep Knowledge Ventures, JHU A-Level Capital, Jim Mellon, Juvenescence
Frequently asked about Insilico Medicine funding
How much has Insilico Medicine raised?
Insilico Medicine has raised $416M in total disclosed funding across the rounds on record.
Who has invested in Insilico Medicine?
Warburg Pincus, Sequoia Capital, Orbimed, Mirae Asset Financial Group, Deep Knowledge Ventures, JHU A-Level Capital are named among the investors backing Insilico Medicine.
What was the latest Insilico Medicine funding round?
The most recent disclosed round is a Series E, announced in June 2025.
Where is Insilico Medicine based?
Insilico Medicine is based in Boston, Massachusetts.
When did Insilico Medicine last raise?
The last disclosed Insilico Medicine round closed in June 2025 at Series E.
Round data for Insilico Medicine is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Boston and backer lists below.
